Medline Industries, Inc. DYNJRA1790Recalls & reported problems

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10193489880441), received between Jan 10, 2023 and Jan 10, 2023 — classified as 1 injury.

The most frequently reported specific device problem is “Break” (1 report).

1 FDA recall record name this device's identifier, 1 still open.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Recalls naming this device

1. Apr 10, 2026Class IOpen, Classified

   Medline kits were distributed containing Huons Bupivacaine Hydrochloride in Dextrose Injection, USP, which was subsequently recalled due to quality issues, including microbiology testing data integrity concerns and reported efficacy complaints.

   Z-2237-2026 · Root cause: Component design/selection · Recall details · FDA record ↗

Most reported problems

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

• InjuryJan 10, 2023Break; Break

  ACCORDING TO THE CUSTOMER, A "SPINAL NEEDLE WAS INSERTED AT L3-L4, THE STYLET WAS REMOVED AND THEN THE OS WAS ENCOUNTERED. ATTEMPTED TO WITHDRAW THE WHITACRE AND INTRODUCER NEEDLE. AT THAT POINT, THE DISTAL 1/3 OF THE WHITACRE NEEDLE WAS NOTED TO BE MISSING." THE CUSTOMER REPORTED THAT THE RETAINED NEEDLE WAS CONFIRMED WITH AN X-RAY.

  Patient problems: Foreign Body In Patient

  MAUDE report 16130600 ↗